Publications by authors named "Xena Li"

Claim this Profile
S
Some assembly required: Comparison of bioinformatic pipelines for analysis of viral metagenomic sequencing from nosocomial respiratory virus outbreaks.
Assad Alhaboub, Natalie M Deschenes, Xena X Li, Victoria R Williams, Kevin C Katz

J Clin Virol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of phenotypic and genotypic susceptibility testing methods for newer β-lactam/β-lactamase inhibitor combinations in multidrug resistant Pseudomonas aeruginosa.
Clayton W Hall, Nicholas Waglechner, Erin Choi, Patryk Aftanas, Kevin Katz, Xena X Li

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing two admission respiratory virus testing strategies during periods of increased SARS-CoV-2 incidence: a multicenter cross-sectional study.
Paige Reason, Amanda Stagg, Victoria Williams, Robert Kozak, Xena Li

Antimicrob Steward Healthc Epidemiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparedness for in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024.
Charlie Tan, Amrita Bharat, Erin McGill, Robyn Mitchell, Olivia Varsaneux, Philippe J Dufresne, Chelsey Ellis, Jennifer Ellison, Linda Hoang, Julianne Kus, Xena Li, Senthuri Paramalingam, Jen Tomlinson, Allison McGeer

Infect Control Hosp Epidemiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Detection of Carbapenemase-Producing Enterobacterales Using a Luminescent Whole-Cell Biosensor.
Mitchell A Jeffs, Shreyas Bhat, Josephine L Liu, Rachel A V Gray, Xena X Li

ACS Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023.
Robyn Mitchell, Laura Mataseje, Joëlle Cayen, Erin McGill, Kristine Cannon, Chelsey Ellis, Jennifer Ellison, Xena Li, Allison McGeer, Jen Tomlinson

Antimicrob Resist Infect Control· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pharyngeal and invasive isolates of by whole-genome sequencing in Toronto, Canada.
Joseph J Zeppa, Ellen G Avery, Patryk Aftanas, Erin Choi, Simone Uleckas, Xena X Li

Microbiol Spectr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of two antimicrobial susceptibility reporting strategies on treatment of bacteremia caused by low-risk AmpC inducible organisms.
Jai Mashru, Marion Elligsen, Nick Daneman, Marie-Félixe Granger, Robert A Kozak, Xena X Li, Philip W Lam

Antimicrob Steward Healthc Epidemiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Laboratory-Confirmed Creutzfeldt-Jakob Disease From 3 Ontario Tertiary Care Centers Between 2012 and 2022: A Retrospective Cohort Study.
Kayla Gaete, Soma Dalai, Ana Cabrera, Xena Li, Prameet M Sheth

Open Forum Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of hybrid whole genome sequencing in assessing potential nosocomial VIM transmission.
David Burke James Mahoney, Xena Li, Patryk Aftanas, Christie Vermeiren, Robert Kozak

Antimicrob Steward Healthc Epidemiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the utility and cost of secondary confirmatory testing for Neisseria gonorrhoeae identification from culture.
Ellen G Avery, Joseph J Zeppa, Donald Brody Duncan, Kevin R Barker, Ramzi Fattouh, Xena X Li

Diagn Microbiol Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Screening Methods.
Adam S Komorowski, Patryk Aftanas, Vanessa Porter, Kevin Katz, Robert A Kozak, Xena X Li

Open Forum Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review.
Carson K L Lo, Adam S Komorowski, Clayton W Hall, Teslin S Sandstrom, Amnah A M Alamer, Xena X Li, Mallika Suresh

Clin Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review.
Adam S Komorowski, Anthony D Bai, Anna Cvetkovic, Omar Mourad, Carson K L Lo, Xena X Li

Clin Microbiol Infect· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?
Adam S Komorowski, Anthony D Bai, Anna Cvetkovic, Omar Mourad, Carson K L Lo, Xena X Li

Antimicrob Agents Chemother· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antibiotic Therapies: A Systematic Review.
Anthony D Bai, Adam S Komorowski, Carson K L Lo, Pranav Tandon, Xena X Li, Laurel Liang

Clin Infect Dis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials.
Anthony D Bai, Adam S Komorowski, Carson K L Lo, Pranav Tandon, Xena X Li, Laurel Liang, George Tomlinson

Trials· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review.
Anthony D Bai, Adam S Komorowski, Carson K L Lo, Pranav Tandon, Xena X Li, Laurel Liang, George Tomlinson

BMC Med Res Methodol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent multidrug-resistant serovar Typhimurium bacteremia in a returned traveller.
Adam S Komorowski, Xena X Li, Eva Piessens, Andrew G McArthur, Ameen Patel

J Assoc Med Microbiol Infect Dis Can· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: A multicenter point-prevalence study.
Anthony D Bai, Xena X Li, Mohammed Alsalem, Sarah Khan, Marek Smieja

Infect Control Hosp Epidemiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Antibiotics May Be Noninferior but Are They Becoming Less Effective?: a Systematic Review.
Anthony D Bai, Adam S Komorowski, Carson K L Lo, Pranav Tandon, Xena X Li, Laurel Liang

Antimicrob Agents Chemother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lyme neuroborreliosis presenting as spinal myoclonus.
Xena Li, Aaron Kirschner, Mary Metrie, Mark Loeb

BMJ Case Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis